~~<i id='80067321AF'><strike id='80067321AF'><tt id='80067321AF'><pre id='80067321AF'></pre></tt></strike></i>~~

Home» focus» Wikipedia

Wikipedia

author：leisure time 2025-09-29 13:54:10 Page View：47113

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Biotech lab space demand falls sharply
Next article： Continuity nursing helped my family in our darkest PICU moments

explore

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

ThisimagereleasedbySonyPicturesshowsPatrickWilsoninScreenGems'"Insidious:TheRedDoor."(SonyPicturesvi

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

Ukraine and a new approach to mental health in war

AUkrainiancadetholdsanartificialflowerinthecoloroftheUkrainianflagontheoutskirtsofKyiv.SERGEISUPINSK